Valproate-induced parkinsonism in epilepsy patient – a case report

Address for correspondence: K. G. Maximov, MD Military Medical Academy – Sofia, Bulgaria Medical Center for Neurology and Neurosurgery „Neuromed” Bul. G. Sofiisky №1 Sofia, Bulgaria tel: 0035929225644 e-mail: neuromaxi@yahoo.com

[1]  G. Rosenberg,et al.  The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? , 2007, Cellular and Molecular Life Sciences.

[2]  A. Pan,et al.  Valproate‐induced Parkinsonism in epilepsy patients , 2007, Movement disorders : official journal of the Movement Disorder Society.

[3]  A. Ristić,et al.  The Frequency of Reversible Parkinsonism and Cognitive Decline Associated with Valproate Treatment: A Study of 364 Patients with Different Types of Epilepsy , 2006, Epilepsia.

[4]  I. Petrov.  Association of patients with parkinsonism and epilepsy with EEG changes. , 2006, PRILOZI.

[5]  H. Masson,et al.  Parkinsonism and/or Cognitive Impairment with Valproic Acid Therapy: A Report of Ten Cases , 2006, Pharmacopsychiatry.

[6]  M. Kellett,et al.  Reversible parkinsonism with normal β-CIT-SPECT in patients exposed to sodium valproate , 2004, Neurology.

[7]  B. Barroso.  [Reversible parkinsonism induced by prolonged treatment with valproate]. , 2002, Therapie.

[8]  Simon Shorvon,et al.  Handbook of Epilepsy Treatment , 2000 .

[9]  M. Onofrj,et al.  Reversible parkinsonism induced by prolonged treatment with valproate , 1998, Journal of Neurology.

[10]  T. Tazawa,et al.  [Valproate induced parkinsonism]. , 1998, No to shinkei = Brain and nerve.

[11]  J. Edinger,et al.  Reversible parkinsonism and cognitive impairment with chronic valproate use , 1996, Neurology.

[12]  E. Sasso,et al.  Reversible Valproate‐Induced Extrapyramidal Disorders , 1994, Epilepsia.

[13]  J. Narbona,et al.  Parkinsonian syndrome in childhood after sodium valproate administration. , 1993, Clinical neuropharmacology.

[14]  A. vanderZwan.  Transient Parkinson syndrome and tremor caused by the use of sodium valproate , 1989 .

[15]  A. van der Zwan.  [Transient Parkinson syndrome and tremor caused by the use of sodium valproate]. , 1989, Nederlandsch tijdschrift voor geneeskunde.

[16]  K. Gale,et al.  Role of the substantia nigra in GABA-mediated anticonvulsant actions. , 1986, Advances in neurology.

[17]  P. Feltz.  Pharmacological evidence about nigro-striatal inhibition related to intrinsic GABA in the caudate nucleus deprived of dopaminergic synaptic activity. , 1979, Applied Neurophysiology.